[Federal Register Volume 65, Number 195 (Friday, October 6, 2000)]
[Notices]
[Page 59849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-25685]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Healthcare Infection Control Practices Advisory Committee 
(HICPAC): Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting.

    Name: Healthcare Infection Control Practices Advisory Committee 
(Formerly Hospital Infection Control Practices Advisory Committee).
    Times and Dates: 8:30 a.m.-5 p.m., November 6, 2000; 8:30 a.m.-4 
p.m., November 7, 2000.
    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE, Atlanta, Georgia 30345.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with providing advice and 
guidance to the Secretary, the Assistant Secretary for Health, the 
Director, CDC, and the Director, National Center for Infectious 
Diseases (NCID), regarding (1) the practice of hospital infection 
control; (2) strategies for surveillance, prevention, and control of 
infections (e.g., nosocomial infections), antimicrobial resistance, 
and related events in settings where healthcare is provided; and (3) 
periodic updating of guidelines and other policy statements 
regarding prevention of healthcare associated infections and 
healthcare-related conditions.
    Matters to be Discussed: Agenda items will include a review of 
proposed revisions to the Guideline for Prevention of Healthcare-
associated Pneumonia, the Guideline for Isolation Precautions in 
Hospitals, the Guideline for Prevention of Intravascular Device-
related Infections, the Guideline for Sterilization and 
Disinfection, the Guideline for Hand Hygiene, and the Guideline for 
Environmental Controls in Healthcare Settings; a discussion of the 
status of Staphylococcus aureus with Reduced Susceptibility to 
Vancomycin (VISA) in the United States; and updates on CDC 
activities of interest to the committee, including nosocomial 
tuberculosis control, the Federal Action Plan for Antimicrobial 
Resistance, and bioterrorism response in healthcare facilities.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Michele L. Pearson, M.D., 
Executive Secretary, HICPAC, Hospital Infections Program, NCID, CDC, 
1600 Clifton Road, NE, M/S A-07, Atlanta, Georgia 30333, telephone 
404/639-6439.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


    Dated: September 28, 2000.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 00-25685 Filed 10-5-00; 8:45 am]
BILLING CODE 4163-18-P